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Critical roles of Bim in T cell activation  
and T cell–mediated autoimmune  
inflammation in mice
Maciej W. Ludwinski, Jing Sun, Brendan Hilliard, Shunyou Gong, Fan Xue, Ruaidhri J. Carmody, 
Jennifer DeVirgiliis, and Youhai H. Chen
Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
Bim,	the	B	cell	lymphoma	2–interacting	(Bcl2-interacting)	mediator,	maintains	immunological	tolerance	by	
deleting	autoreactive	lymphocytes	through	apoptosis.	We	report	here	that	Bim	is	also,	paradoxically,	required	
for	the	activation	of	autoreactive	T	cells.	Deletion	of	Bim	in	hematopoietic	cells	rendered	mice	resistant	to	
autoimmune	encephalomyelitis	and	diabetes,	and	Bim-deficient	T	cells	had	diminished	cytokine	production.	
Upon	T	cell	receptor	activation,	Bim-deficient	T	cells	exhibited	severe	defects	in	both	calcium	release	and	
dephosphorylation	of	nuclear	factor	of	activated	T	cells	(NFAT)	but	maintained	normal	levels	of	activation	of	
NF-κB	and	MAPKs.	The	defective	calcium	signaling	in	Bim-deficient	T	cells	was	associated	with	a	significant	
increase	in	the	formation	of	an	inhibitory	complex	containing	Bcl2	and	the	inositol	triphosphate	receptor	
(IP3R).	Thus,	in	addition	to	mediating	the	death	of	autoreactive	T	cells,	Bim	also	controlled	T	cell	activation	
through	the	IP3R/calcium/NFAT	pathway.	These	results	indicate	that	a	single	protein	is	used	to	control	both	
the	activation	and	apoptosis	of	autoreactive	T	cells	and	may	explain	why	Bim-deficient	mice	do	not	reject	their	
own	organs	despite	lacking	thymic	negative	selection.
Introduction
Apoptosis, or programmed cell death, is essential for the mainte-
nance of cellular homeostasis in multicellular organisms. It is char-
acterized by a controlled destruction of cellular structures through 
proteolysis of vital cellular components. Apoptosis can be medi-
ated by at least 2 distinct pathways: the mitochondrial pathway 
(also called the stress or intrinsic pathway) and the death receptor 
pathway (also called the extrinsic or mitochondria-independent 
pathway). Unlike the death receptor pathway, which is activated 
by death ligands, the mitochondrial pathway is activated by agents 
that perturb, either directly or indirectly, the integrity of the mito-
chondrial outer membrane. These include cytotoxic cytokines, 
antigens, and reactive oxygen species (1–3). The “stressed” mito-
chondria release cytochrome c to the cytosol, which in turn acti-
vates the caspase cascade through Apaf-1 and caspase-9 (4). Unlike 
the death receptor pathway, the mitochondrial pathway is directly 
controlled by the B cell lymphoma 2 (Bcl2) family of proteins.
The Bcl2 family consists of 3 classes of proteins that can either 
promote or inhibit the mitochondrial pathway of apoptosis (5, 6). 
The first class is called Bcl2-like antiapoptotic factors. These factors all 
contain 3 to 4 Bcl2 homology (BH) domains, which are required 
for their antiapoptotic function. This group includes Bcl2, Bcl-xL, 
Bcl-w, A1/Bfl-1, Boo/Diva/Bcl-B, and Mcl-1 (5, 6). Bcl2 is the best-
characterized member of this group. It blocks apoptosis by pre-
serving the integrity of the outer mitochondrial membrane, thus 
preventing cytochrome c release. It neutralizes the activities of pro-
apoptotic members of the family by directly interacting with them. 
Bcl2-deficient mice show defects in renal development and under-
go premature loss of lymphoid cells and melanocytes, resulting 
in immunodeficiency and loss of hair pigmentation, respectively 
(7). The second class is called Bax-like proapoptotic factors. These fac-
tors contain BH1–BH3 domains, which act exclusively in a pro-
apoptotic fashion. This group consists of Bax, Bak, and Bok/Mtd 
(5, 6). The third class is called BH3-only proapoptotic factors. These 
members share only a 9–amino acid BH3 domain with other Bcl2 
family members. They include Bim (Bcl2-interacting mediator), 
Bid, Bad, Bik/Nbk, Blk, Hrk/DP5, Noxa, Puma/Bbc3, Bnip3, Bmf, 
and Bcl-GS (1, 5, 6).
Bim was initially identified as a Bcl2-interacting protein (8). It 
exists in several isoforms, of which BimS, BimL, BimEL, BimAD, and 
BimG seem to be the most potent inducers of apoptosis (8, 9). Bim 
is constitutively expressed in many cell types but is maintained in 
an inactive form through binding to the microtubule-associated 
dynein motor complex (10). Cytokines, antigens, and cytotoxic 
agents can activate the Bim pathway through at least 3 different 
mechanisms: (a) by releasing it from the dynein motor complex 
or the antiapoptotic members of the Bcl2 family; (b) by increas-
ing its mRNA level through transcriptional regulation; and (c) by 
increasing its protein level through proteasome-dependent regula-
tion of protein degradation (1–3). For example, TCR ligation can 
significantly increase Bim protein levels in T cells (11). Cytokines 
that activate JNK or the forkhead family of transcriptional fac-
tors can also regulate Bim expression and function (12–14). The 
mechanisms through which Bim induces apoptosis are not well 
understood. Recent studies indicate that Bim acts upstream of Bax 
and may directly activate Bax and Bak-like proteins in certain cell 
types (3, 15, 16). This has led to the recognition that Bim serves as 
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a key initiator of the mitochondrial pathway of apoptosis. How-
ever, direct interaction of Bax with Bim was observed in some cells 
(e.g., neurons) (12, 16) but not others (8). Additionally, Bim may 
also initiate apoptosis by neutralizing or modifying Bcl2 or Bcl2-
like prosurvival proteins (1, 2, 17). Bim is critical for apoptosis and 
homeostasis in the lymphoid and myeloid compartments. Bim-
knockout mice have abnormally high numbers of lymphoid and 
myeloid cells (17). T cells, B cells, granulocytes, and monocytes are 
increased 2- to 4-fold in peripheral tissues compared with those in 
WT animals. With age, Bim-knockout mice develop splenomegaly, 
lymphadenopathy, and hypergammaglobulinemia (17). Using 
experimental models of negative selection, Bouillet et al. discovered 
that Bim-deficient mice have a severe defect in negative selection of 
autoreactive T cells in the thymus (11). Death of thymocytes recog-
nizing superantigens (Mtv9 and Staphylococcus enterotoxin B) and 
male antigen HY was almost completely blocked in Bim–/– mice 
(11). Deletion of antigen-activated T cells during the shutdown of 
immune responses is also hindered in these mice (18).
While it is well recognized that members of the Bcl2 family are 
crucial regulators of the mitochondrial pathway of apoptosis, the 
roles of most of these proteins in organ-specific autoimmune dis-
eases are not known. We report here that Bim plays an unexpected 
role in T cell activation and T cell–mediated autoimmunity.
Results
Bim deficiency in hematopoietic cells renders mice resistant to autoimmune 
encephalomyelitis and diabetes. To determine the roles of Bim in autoim-
munity, we first studied EAE in Bim–/– mice. Young Bim–/– mice (<14 
weeks old) are healthy and do not have developmental problems, 
whereas old Bim–/– mice (>14 weeks old) develop lymphadenopa-
thy and inflammatory kidney diseases (17). For these reasons, only 
5- to 7-week-old young mice were used in this study. Thus, Bim–/– 
C57BL/6 mice and their WT littermate controls were immunized 
with myelin oligodendrocyte glycoprotein 38–50 (MOG 38–50) 
peptide and monitored for EAE by both physical examination and 
histochemistry (19). EAE developed in all (100%) control mice, start-
ing approximately 6 days after immunization (Figure 1A). The dis-
ease took a chronic progressive course, with a 30% mortality rate. In 
contrast, in the Bim–/– group, only 50% of mice developed symptoms 
of EAE, and no mice died of the disease. The onset of the disease was 
delayed by approximately 4 days (14 ± 1.1 and 10 ± 0.9 days in WT 
and Bim–/– mice, respectively; P < 0.05), whereas recovery significantly 
accelerated in Bim–/– mice (18% and 100% in WT and Bim–/– mice, 
respectively; P < 0.05). Consistent with these clinical findings, the 
degree of encephalomyelitis was also significantly reduced in the 
Bim–/– group (Figure 2, A and B).
Since Bim is expressed not only by cells of the immune system 
but also by cells of the central nervous system, we next investigated 
whether Bim expressed by different organ systems played different 
roles in EAE. Thus, bone marrow chimeric mice were generated 
by either injecting WT bone marrow cells into irradiated Bim–/– or 
WT recipients (Figure 1B) or by injecting Bim–/– or WT bone mar-
row cells into irradiated WT recipients (Figure 1C). Mice were then 
immunized with MOG peptide to induce EAE as in Figure 1A. 
Remarkably, Bim deficiency in bone marrow–derived cells alone 
was sufficient to prevent EAE (Figure 1C), whereas Bim deficiency 
in non–bone marrow–derived cells had no effect (Figure 1B). The 
frequency and/or the number of donor-derived cells in the recipi-
ent mice was determined by flow cytometry before immunization 
and after the end of the experiment. Although the percentages of 
lymphoid and myeloid cells were comparable in mice that received 
WT and Bim-deficient cells, the number of donor-derived cells 
was increased by approximately 2-fold in the spleens of mice that 
received Bim-deficient cells as compared with those that received 
WT cells. Taken together, these results indicate that Bim expressed 
by hematopoietic cells plays an indispensable role in the develop-
ment of autoimmune inflammation in the CNS.
To determine whether the roles of Bim observed in EAE could 
be extended to other autoimmune disease models, we studied 
type 1 diabetes (T1D) in both C57BL/6 and NOD.C57BL/6 con-
genic mice. Consistent with previous reports (20, 21), multiple 
low-dose injections of streptozotocin (STZ) induced diabetes in 
approximately 54% of WT C57BL/6 mice, which was characterized 
by severe hyperglycemia (Supplemental Figure 1, A and B; supple-
mental material available online with this article; doi:10.1172/
JCI37619DS1) and insulitis (Supplemental Figure 2). In contrast, 
only 15% of Bim–/– C57BL/6 mice developed STZ-induced diabe-
tes, with significantly reduced insulitis (Supplemental Figure 1, A 
Figure 1
Effects of Bim deficiency on the development of autoimmune encepha-
lomyelitis. Five -to six-week-old WT and Bim–/– C57BL/6 mice (n = 6) 
(A), irradiated CD45.1+ WT and CD45.2+ Bim–/– C57BL/6 mice (n = 6) 
that received CD45.1+ WT bone marrow (B), and irradiated CD45.1+ 
WT C57BL/6 mice (n = 6) that received CD45.1+ WT or CD45.2+ 
Bim–/– bone marrow (C) were immunized with MOG to induce EAE 
as described in Methods. Data are presented as mean ± SD of EAE 
scores and are representative of 2–3 independent experiments. The 
differences between WT and Bim–/– groups are statistically significant 
(P < 0.001) for panels A and C but not B.
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and B, and Supplemental Figure 2). More strikingly, Bim–/– NOD.
C57BL/6 congenic mice were completely resistant to the develop-
ment of diabetes even after 2 administrations of cyclophosphamide 
(CY), which is known to significantly accelerate T1D; in contrast, 
approximately 80% of NOD.C57BL/6 WT littermates developed 
T1D under the same conditions. Spontaneous diabetes could not 
be studied in Bim–/– mice because of their significantly reduced life 
span (17). CY may accelerate the development of T1D by inducing 
apoptosis of Treg cells (22). However, we found that CY-induced 
apoptosis of Tregs as well as that of CD4+, CD8+, and CD19+ cells 
was not affected by Bim deficiency (our unpublished data).
To determine whether Bim deficiency in T lymphocytes was 
responsible for the reduced diabetes in Bim-deficient mice, we 
transferred WT and Bim–/– splenic T cells into Rag1-knockout mice 
(which do not have lymphoid cells). One week after T cell transfer, 
mice were injected with low-dose STZ for 5 days to induce diabe-
tes. By the fourth week, 60% of mice that received WT T cells devel-
oped diabetes with severe hyperglycemia; in contrast, only 18% of 
mice that received Bim-deficient T cells developed T1D (Supple-
mental Figure 3). Rag1-knockout mice that received no T cells did 
not develop T1D (our unpublished data). Taken together, these 
results establish that Bim expressed by T cells plays a crucial role 
in the development of autoimmune diseases.
It is to be noted that although the total numbers of CD4+CD25+ 
Treg cells and CD4+CD25– non-Treg cells were significantly 
increased in the spleens of aged Bim-deficient mice as compared 
with WT mice, the percentages of these cell types were not affected 
by the Bim deficiency. Additionally, Bim does not appear to medi-
ate cyclophosphamide-induced death of lymphocytes in vivo. 
Specifically, 4 days after a single injection of cyclophosphamide 
(200 mg/kg), the total number of splenic Treg cells was reduced 
by 42% and 38% in WT and Bim-deficient NOD mice, respectively, 
whereas those of CD4+CD25– non-Treg cells were reduced by 45% 
and 44% in WT and Bim-deficient NOD mice, respectively. CD19+ 
B cells were more sensitive to cyclophosphamide-induced death; 
these percentages were reduced by 83% and 86% in WT and Bim-
deficient NOD mice, respectively.
Bim-deficient mice develop reduced T cell responses to self-neural and pan-
creatic antigens. Autoreactive T cells are both initiators and effectors 
of EAE and T1D. To determine whether activation and differentia-
tion of autoreactive T cells are normal in Bim-deficient animals, 
splenocytes were collected from Bim–/– and WT mice and stimulat-
ed in vitro with purified self antigens. When stimulated with MOG 
peptide, Bim–/– splenocytes from MOG-immunized C57BL/6 mice 
proliferated similarly to WT cells (Figure 2C). However, they pro-
duced significantly less IL-2, IL-6, and IFN-γ than WT cells (Figure 
2, D–F). Similarly, when stimulated with insulin or glutamic acid 
decarboxylase 65 (GAD65), antigens involved in the pathogenesis 
of T1D, Bim–/– splenocytes from NOD.C57BL/6 mice produced 
significantly less IL-2 and IFN-γ than WT cells (Supplemental 
Figure 2
Reduced neural inflammation and anti-
myelin T cell immunity in Bim-deficient 
mice. (A and B) Mice (n = 6) were 
treated as in Figure 1A and sacrificed 
31 days after immunization. Spinal cord 
sections were stained with H&E. (A). 
Original magnification, ×200. Data in 
panel B represent mean + SD of patho-
logical scores of all mice (n = 6), with 10 
sections per mouse examined. (C–F) 
Mice were treated as in Figure 1A and 
sacrificed 10 days after immunization. 
Splenocytes, 5 × 106/well, were cultured 
with or without different concentrations 
of MOG38–50 peptide. Culture superna-
tants were collected 40 hours later and 
tested for cytokines by ELISA. For pro-
liferation assay, cells were pulsed with 
3H-thymidine and radioactivity deter-
mined 16 hours later. Data presented 
are representative of 3 experiments. 
*P < 0.05; **P < 0.01.
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Figure 4). Of note is that the effect of Bim deficiency on IFN-γ 
production appears to be antigen and dose dependent, with the 
25 μg/ml MOG-induced response the least affected. These results 
indicate that Bim may be required for the activation and function 
of autoreactive T cells.
Bim-deficient T cells are defective in their cytokine gene expression fol-
lowing TCR activation. To determine whether Bim–/– T cells have an 
intrinsic defect in TCR-mediated activation, we purified CD4+ 
T cells and stimulated them with different concentrations of anti-
CD3 and anti-CD28. We found that Bim–/– T cells had a global 
defect in cytokine production affecting all cytokines tested, which 
included IL-2, IL-4, IL-6, IL-10, IL-17A, and IFN-γ (Figure 3). Con-
sistent with these results, overexpression of Bim in EL-4 T cells 
significantly increased IL-2 production (Supplemental Figure 5). 
The defect in Bim–/– T cells appears to lie upstream of the cytokine 
synthesis because mRNA expression of selected cytokines (IL-2, 
IL-6, and IL-17A) was also significantly reduced in these cells (Fig-
ure 4, A–C). However, despite an increase in p27 levels (Supple-
mental Figure 6), Bim–/– T cells did not show a significant defect 
in proliferation (our unpublished data). Additionally, following 
stimulation with phorbol myristate acetate (PMA) and ionomy-
cin, Bim–/– T cells expressed levels of cytokines similar to those of 
WT T cells (Figure 4D and our unpublished data). Because PMA 
and ionomycin stimulate T cells by activating protein kinase C and 
promoting calcium release from the ER, these results indicate that 
the defect in Bim–/– T cells may lie proximal to the TCR.
Bim-deficient T cells have a selective defect in the calcium/nuclear factor 
of activated T cells signaling pathway. To determine which signaling 
pathway is regulated by Bim, we studied TCR-induced activation 
of MAPK, NF-κB, and nuclear factor of activated T cells (NFAT) 
pathways in WT and Bim–/– T cells. We found that activation-asso-
ciated phosphorylation of JNK, ERK, and IκB was not affected 
by the Bim gene mutation (Figure 5A), indicating that the MAPK 
and NF-κB signaling pathways are normal in Bim–/– T cells. In 
contrast, NFATc2 dephosphorylation, a critical step required for 
NFAT nuclear translocation and subsequent NFAT target gene 
activation, was significantly blocked in Bim–/– T cells (Figure 5, A 
and B). Thus, without TCR activation, NFATc2 existed primarily 
as a hyperphosphorylated protein in WT and Bim-deficient T cells 
(Figure 5, A and B). Upon anti-CD3 stimulation of WT T cells, 
essentially all NFATc2 proteins were dephosphorylated, leading 
to a significant reduction in their molecular weight. In contrast, 
only a marginal increase in dephosphorylated NFATc2 was noted 
in anti-CD3–treated Bim–/– T cells, with a significant portion of 
NFATc2 remaining phosphorylated.
NFAT dephosphorylation is mediated by calcineurin, a serine 
phosphatase that is activated by calcium/calmodulin follow-
ing TCR ligation. To determine whether the calcium signaling is 
affected by Bim deficiency, we tested calcium release in T cells fol-
lowing TCR stimulation. We found that although calcium release 
occurred in Bim–/– T cells, its peak value was significantly reduced 
as compared with that in WT T cells (Figure 5C). The reduction 
in calcium flux was observed in Bim-deficient T cells treated with 
various concentrations of anti-CD3, i.e, 1, 3, and 9 μg/ml. Taken 
together, these results establish that Bim–/– T cells have a signifi-
cant defect in their calcium/NFAT signaling pathway.
Figure 3
Defective cytokine production by Bim-defi-
cient CD4+ T cells. CD4+ T cells isolated 
from naive WT and Bim–/– C57BL/6 mice 
(n = 4), 5–6 weeks of age, were cultured 
in 96-well plates with different amounts 
of plate-bound anti-CD3 (0–5 μg/ml) and 
2 μg/ml soluble anti-CD28. Culture super-
natants were collected 18 hours later, and 
cytokine concentrations were determined 
by ELISA. Data show mean + SD of tripli-
cate cultures and are representative of 3 
independent experiments. *P < 0.01.
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Bcl2 can modulate ER Ca+2 release by forming a protein complex 
with inositol triphosphate receptor (IP3R) on the ER (23, 24). To 
determine whether Bim interferes with this process, we measured 
the interaction between Bcl2 and IP3R by immunoprecipitation 
(Supplemental Figure 7). We found that Bcl2 associated with IP3R in 
murine T cells, an association that was slightly increased upon T cell 
activation. Bim deficiency significantly increased Bcl2:
IP3R interaction, especially under activating conditions 
(Supplemental Figure 7). These data indicate that Bim 
may regulate T cell activation through IP3R.
The frequency of self-antigen–reactive T cells in Bim-defi-
cient mice. Although it has been clearly demonstrated 
that negative selection of thymocytes recognizing 
super-antigens and male antigen HY was blocked in 
Bim–/– mice (11), to what degree Bim mediates the dele-
tion of autoreactive cells involved in EAE and T1D has 
never, to our knowledge, been examined. To address 
this issue, we first examined the frequencies of myelin- and insu-
lin-reactive T cells in WT and Bim–/– mice by limiting dilution 
analysis (LDA) (25–27). Thus, splenic T cells were diluted in 2-fold 
steps in 96-well plates and mixed with a variable number of feeder 
cells (irradiated splenic cells). IL-2 and a self antigen (inactivated 
insulin, myelin basic protein [MBP], or MOG38–50 peptide) were 
added to each culture to expand the specific T cells. Fourteen days 
later, cells were restimulated with the same self antigens and their 
proliferation measured. Fractions of negative and positive cul-
tures were used to calculate the frequencies of antigen-reactive 
T cells by X2 minimization (25–27). Unexpectedly, we found that 
the frequency of T cells responding to each of the self antigens 
was significantly reduced in Bim–/– mice (Table 1). These results 
indicate that, regardless of the potential roles of Bim in the nega-
tive selection of myelin- and insulin-specific T cells, the “effective 
frequency” of these cells, i.e., the frequency of cells that can mount 
a detectable response to their antigens, is reduced in Bim–/– mice. 
Because Bim–/– T cells have significant defects in their responses 
to antigen stimulation, which are measured by LDA, the reduced 
“effective frequency” of self-reactive T cells in Bim–/– mice may sim-
Figure 4
Defective cytokine mRNA expression in Bim-deficient CD4+ T cells. 
CD4+ T cells isolated as in Figure 3 were stimulated with (A–C) 5 μg/ml 
plate-bound anti-CD3 and 2 μg/ml soluble anti-CD28 or (D) 50 ng/ml 
PMA and 50 ng/ml ionomycin for the indicated times. Cytokine mRNA 
levels were determined by quantitative real-time PCR. The experi-
ments were repeated 3 times with similar results. The differences 
between WT and Bim–/– groups are statistically significant (P < 0.01) 
for all cultures with anti-CD3 and anti-CD28 (A–C) but not for those 
with PMA and ionomycin (D). Error bars represent SD.
Figure 5
Defective NFAT activation and calcium influx of Bim-defi-
cient CD4+ T cells. (A) CD4+ T cells were treated with 
anti-CD3 and anti-CD28 as in Figure 4A for the indicated 
times. Whole-cell lysates were blotted with antibodies to 
total or phosphorylated (p) IκBα, JNK1/2, ERK1/2, and 
NFATc2 as well as β-actin and p65. d-NFAT, dephos-
phorylated NFATc2. (B) Relative band intensities of 
phosphorylated NFATc2 (upper panel) and dephosphory-
lated NFATc2 (lower panel) shown in panel A as deter-
mined by densitometry. (C and D) CD4+ T cells were treat-
ed as described in Methods to measure anti-CD3–induced 
[Ca+2] flux (C). Cells with [Ca+2] levels above background 
were considered as responding to the stimulation (D). Dif-
ference in peak [Ca+2] levels between WT and Bim–/– cells 
is statistically significant (*P < 0.01). Difference in the per-
centage of cells responding is not statistically significant. 
Experiments were repeated 3 times with similar results.
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ply be a result of their reduced responsiveness. However, because 
the total number of splenocytes in Bim–/– mice was increased as 
compared with those in WT mice, Bim–/– mice do not have sig-
nificantly reduced total numbers of self-reactive T cells, with the 
exception of insulin-reactive cells (Table 1).
Discussion
Tissue homeostasis depends on the tight control of the balance 
between cell proliferation and death. There is a growing list of pro-
teins, such as c-Myc, p53, Ras, and NF-κB, that have dual roles in 
cell-cycle control and apoptosis. Recently, the Bcl2 family of pro-
teins has also been implicated in controlling cell-cycle progression 
and proliferation. The first connection between Bcl2 and cell-cycle 
control was discovered in murine bone marrow–derived Baf3 cells. 
Overexpression of Bcl2 resulted in an arrest at the G1 phase of 
the cell cycle (28). Further experiments revealed that T and B cells 
from Bcl2 transgenic mice entered the cell cycle with delayed kinet-
ics and thymocyte turnover was delayed (28). On the other hand, 
T cells deficient in Bcl2 demonstrated increased cell-cycle progres-
sion and proliferation, whereas overexpression of Bax blocked the 
antiproliferative effect of Bcl2 (29).
In addition to regulating cell cycle and apoptosis, Bcl2 family 
members have also been implicated in controlling cell activation. 
Both Bcl2 and Bcl-xL can form a protein complex with IP3R on the 
ER and modulate ER Ca+2 release (23, 24). It is believed that phos-
phorylation of Bcl2 by JNK at the ER membrane may regulate the 
antiapoptotic activity of Bcl2 negatively, causing decreased bind-
ing to BH3-only proteins and increasing ER Ca+2 content (30). Bax 
and Bak are also implicated in controlling ER Ca+2 homeostasis 
and the regulation of T cell proliferation (31). Bax and Bak dou-
ble-knockout cells are defective in ER Ca+2 flux upon stimulation, 
which appears to be dependent on Bcl2 and IP3R (23). The balance 
between antiapoptotic and proapoptotic proteins at the ER may 
determine the steady state of ER Ca+2 content and have a direct 
impact on the amount of Ca+2 released after stimulation. This 
may in turn affect many cellular processes, including cell activa-
tion and proliferation.
Our data indicate that the balance between antiapoptotic and 
proapoptotic Bcl2 family members extends beyond the control of 
apoptosis and proliferation. Bim and Bcl2 may act in opposition 
to alter T cell activation through modulation of ER calcium flux. 
In order for Bcl2 members to adequately control apoptosis, they 
must sequester proapoptotic proteins to prevent cell death. The 
amount of free Bcl2 available to bind IP3R is likely dependent on 
the levels of proapoptotic proteins, such as Bim. Under normal 
conditions in T cells, a fraction of Bcl2 protein is available to bind 
to IP3R on the ER. By interacting with Bcl2, Bim can affect not 
only cell death but also the amount of free Bcl2 available to bind 
IP3R. This in turn controls other cellular responses such as T cell 
activation, as we demonstrated here. Because Bim has been found 
to be associated with ER membranes, it is also possible that it may 
modulate ER calcium release directly (32).
Thus, Bim may regulate the fates of autoreactive T cells through 
2 different pathways: (a) the mitochondria apoptosis path-
way, through which it mediates negative selection of autoreac-
tive immature T cells (11); and (b) the calcium/NFAT pathway, 
through which it controls the activation of mature T cells. How-
ever, many T cells recognizing self antigens, e.g., MOG, may not 
undergo thymic negative selection. Indeed, MOG peptide–specific 
T cells are not deleted or tolerized in transgenic mice expressing 
the MOG-specific TCR (33). Therefore, Bim-mediated thymic 
selection may not operate in the MOG-induced EAE model stud-
ied here. Although Bim may be involved in the thymic deletion of 
T cells recognizing MBP and insulin, our demonstration that the 
“effective frequency” of these cells was decreased in Bim–/– mice 
indicates that Bim’s effect on T cell activation may prevail in vivo. 
This may explain why Bim–/– mice, despite their defect in negative 
selection, do not reject their own organs. Similar results have been 
reported for Bax–/– mice following immunization with a MOG 
peptide (34). Neither young nor old Bax–/– mice develop lymph-
adenopathy or spontaneous autoimmune diseases (35). But both 
clinical manifestations of EAE and oligodendrocyte death were 
reduced in Bax–/– mice (34). Thus, deficiency in either Bim or Bax 
is sufficient to prevent EAE.
In summary, our unexpected observation that Bim–/– mice are 
resistant to EAE and T1D led to the discovery of what we believe 
is a previously unrecognized function of Bim in T cell activa-
tion. This finding will have significant ramifications for our 
understanding of the mechanisms of immune homeostasis and 
autoimmune diseases.
Methods
Mice and cell transfer. Bim–/– 129/SvJ mice were generated by replacing the 
BH3-encoding exon of the Bim gene with a neo cassette flanked by LoxP sites 
as described (17). The neo cassette was later removed from Bim–/– mice by 
crossing them with the Cre-expressing deleter mice (17). To generate Bim–/– 
C57BL/6 mice, Bim–/+ 129/SvJ × C57BL/6 F2 mice were backcrossed to 
C57BL/6 background for 10 generations. To generate Bim–/+ NOD.C57BL/6 
congenic mice, Bim–/+ mice were backcrossed to NOD background for 8 
generations. Bim–/– congenic mice were then generated by crossing Bim–/+ 
mice. The Bim gene mutation was tracked by genomic PCR as described 
(17). To generate bone marrow chimeric mice, recipient CD45.1+ or CD45.2+ 
C57BL/6 mice were irradiated with 2 doses of 5 Gy each. They were then 
i.v. injected with 107 bone marrow cells collected from CD45.1+ or CD45.2+ 
donor mice. Eight weeks following bone marrow reconstitution, mice were 
used for experiments described in this study. For T cell transfer, 107 CD4+ 
T cells isolated from spleens were injected into Rag1–/– C57BL/6 mice 
through the tail vein. Twenty-four hours after the transfer, mice were used 
for the disease studies. All procedures were preapproved by the University 
of Pennsylvania Institutional Animal Care and Use Committee. Bim–/– mice 
were a gift from Andreas Strasser and Bouillet Philippe (The Walter and 
Eliza Hall Institute of Medical Research, Melbourne, Australia).
Cell culture and reagents. Splenocytes or CD4+ T cells isolated by magnetic 
sorting were cultured in complete DMEM containing 10% FBS, 100 U/ml 
penicillin, 100 μg/ml streptomycin, 30 μM β-mercaptoethanol, 1 mM 
sodium pyruvate, 10 mM HEPES, and 1× nonessential amino acids (36). 
Table 1
Effective frequencies of autoreactive T cells
Antigens	 Genotypes	 Responders		 Responders	
	 	 per	107	T	cells	 per	spleen
MOG38–50 WT 57.5 457.7
MOG38–50 Bim–/– 46.2 1177.3
Insulin WT 52.4 208.3
Insulin Bim–/– 4.6 41.8
MBP WT 17.8 70.9
MBP Bim–/– 6.8 60.9
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Anti-CD3 and anti-CD28 were purchased from eBioscience. MOG38–50 
peptide was synthesized by Invitrogen. Pertussis toxin was purchased from 
List Biological Laboratories Inc. CFA was purchased from DIFCO Laborato-
ries. Anti-NFATc2 (4G6-C5) antibody was from Santa Cruz Biotechnology 
Inc. Anti–phospho-IκBα (Ser32), anti-IκBα, anti–phospho-JNK, anti-JNK, 
anti–phospho-p44/42 MAPK, and anti-p44/42 MAPK antibodies were from 
Cell Signaling Technology. Anti-p65 antibody was from eBioscience.
Induction and evaluation of EAE. EAE was induced as described (37). In 
brief, mice first received a s.c. immunization with 300 μg MOG38–50 
peptide emulsified in CFA and an i.v. injection of 200 ng pertussis toxin. 
A second injection of 200 ng pertussis toxin was given 48 hours later. Mice 
were examined daily for clinical signs of EAE and scored as follows: 0, no 
disease; 1, tail paralysis; 2, hind limb weakness; 3, hind limb paralysis; 
4, hind limb plus forelimb paralysis; and 5, moribund or dead. For path-
ological analysis, spinal cord and brain were sectioned and stained with 
H&E or luxol fast blue and cresyl violet. The degree of inflammation was 
scored by a blinded observer as follows: 0, no white matter infiltration or 
demyelination; 1, mild infiltration; 2, moderate infiltration; and 3, exten-
sive infiltration with demyelination throughout the white matter.
Induction and evaluation of T1D. To induce diabetes with STZ, C57BL/6 
mice were injected i.p. for 5 consecutive days with 40 mg/kg STZ. To induce 
diabetes with CY, NOD mice, 6 to 7 weeks old, were injected with 200 mg/kg 
of CY on days 0 and 7. Tail-vein blood glucose levels were measured twice a 
week with a FreeStyle blood glucose meter (Abbott). Mice were considered 
diabetic when glucose levels were greater than or equal to 250 mg/dl on 2 
consecutive tests. For pathological analysis, pancreata were sectioned and 
stained with H&E. The degree of islet inflammation was graded as follows: 
0, no inflammation; 1, peri-insulitis with mononuclear cell infiltration 
affecting 25% or less of the circumference; 2, peri-insulitis with mononucle-
ar cell infiltration affecting more than 25% of the circumference; 3, moder-
ate insulitis with intraislet mononuclear cell infiltration but good preserva-
tion of islet architecture; and 4, severe insulitis with numerous intraislet 
inflammatory cells and loss of normal islet architecture.
LDA. Splenocytes were isolated from 8 WT and 4 Bim-knockout C57BL/6 
mice at 6 weeks of age. Cells were diluted in 2-fold steps and mixed with 
variable numbers of feeder cells (irradiated splenocytes from C57BL/6 
mice) so that the final concentration of cells was 5 × 106 cells/well. Cells 
were cultured in 96-well plates in complete medium for 14 days with 50 
units/ml of recombinant IL-2 and 50 μg/ml of insulin (heat inactivated), 
MBP, or MOG peptide. A total of 24 wells were used for each dilution, 
with an equal number of wells cultured without antigen. After incubation, 
cells were washed and split into 2 separate cultures mixed with 5 × 105 
feeder cells/well. Cells were cultured for another 3 days with or without the 
respective antigens. During the last 16 hours of the culture, [3H]-thymidine 
was added. Radioactivity was measured using a beta counter. Cultures were 
considered positive when the cpm were 3 SDs above the means of cultures 
without antigen. The frequency of responders was calculated by plotting 
the log of the fraction of negative cultures versus the cell dose. A line was 
fitted to the plotted points. The frequency of precursors was extrapolated 
directly by drawing a line from 0.37 to the point where that line intersected 
with the fitted line. 
Real-time PCR. Total RNA was extracted using TRIzol reagent (Invitrogen). 
cDNA was synthesized using reverse transcriptase II (Invitrogen). Real-
time quantitative PCR was performed using the SYBR Green Master Mix 
(Applied Biosystems). Data were normalized to β-actin mRNA.
Enzyme-linked immunosorbent assay. Antibodies used in ELISA were pur-
chased from BD Pharmingen, including purified and biotinylated rat anti-
mouse IL-2, IL-4, IL-6, IFN-γ, and IL-17A. Quantitative ELISA was per-
formed using paired mAbs specific for corresponding cytokines according 
to the manufacturer’s recommendations.
Western blot. Total cell lysate was prepared by suspending cells in RIPA 
buffer containing 150 mM NaCl, 10 mM Tris (pH 7.4), 0.1% SDS, 1% Tri-
ton X-100, 1% sodium deoxycholate, 100 μM Na3VO4, 5 mM EDTA, 1 mM 
PMSF, and protease inhibitor cocktail. Proteins (20 μg/lane) were resolved 
by SDS-PAGE, transferred to a nitrocellulose membrane, and blotted with 
specific antibodies (36).
Calcium measurement. Single-cell suspensions of mesenteric lymph nodes, 
107 cells per group, were washed twice in RPMI containing 2% FBS and 
resuspended in the staining buffer, which contained 1 ml RPMI, 10 μl FBS, 
20 μl probenecid, 1.5 μl indo-1 in DMSO, 4 μl anti–CD4-APC, 4 μl biotin 
anti-CD3, and 4 μl biotin anti-CD4. Cells were incubated in the dark at 
30°C for 30 minutes. After incubation, cells were washed and resuspended 
in cold serum-free RPMI. Analysis was performed on an LSR II Flow 
Cytometer (BD). Samples were first run for 90 seconds and then treated 
with a warm mix of RPMI and streptavidin (1:50 dilution) to enable anti-
body cross-linking. Samples were run for an additional 3.5 minutes. Analy-
sis was performed using FlowJo software, version 7 (Tree Star).
Statistics. Disease severity, day of onset, calcium flux, and cytokine con-
centrations were analyzed by 2-tailed Student’s t test. Disease scores were 
analyzed by Mann-Whitney U test. P < 0.05 was considered significant.
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